Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of ZT006 tablets in overweight or obese adults
CTR20254183Phase 2Active
- Sponsor
- Quality Peptide
- Start
- Dec 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ZT006 in obesity, Overweight, sponsored by Quality Peptide. Started Dec 2025; status: active.
02
Drugs
ZT006
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20254183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254183.